Potential limitations of plasmapheresis in treatment of COVID-19 patients: How to overcome them?
Ther Apher Dial
.
2021 Jun;25(3):350.
doi: 10.1111/1744-9987.13568.
Epub 2020 Aug 18.
Authors
Ahmed M Daoud
1
,
Karim M Soliman
2
,
Hatem K Ali
3
Affiliations
1
Nephrology Division, Internal Medicine Department, Cairo University Medical School, Cairo, Egypt.
2
Nephrology Division, Internal Medicine department, Medical University of South Carolina, Charleston, South Carolina, USA.
3
Nephrology Division, Internal Medicine Department, University Hospitals of Birmingham, Birmingham, UK.
PMID:
32710694
DOI:
10.1111/1744-9987.13568
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Humans
Plasmapheresis
SARS-CoV-2